Furnish and Delivery of Sodium Bisulfite Solution 38% SBR Procurement

Project: Furnish and Delivery of Sodium Bisulfite Solution 38% SBR Procurement Ref. #: 1-24-2-32-5R Type: IFB Status: Open Open Date: Feb 27th 2024, 9:00 AM EST Intent to Bid Due Date: Mar 8th 2024, 12:00 PM EST Questions Due Date: Mar 1st 2024, 12:00 PM EST Close Date: Mar 8th 2024, 12:00 PM EST Days Left: 5 Project Description:The Maryland Environmental Service (MES) is requesting sealed Bids from qualified chemical manufacturers/distributors to furnish and deliver Sodium Bisulfite Solution 38% in gallon bulk to Cambridge Wastewater Treatment Plants. The quantity of 18,000 gallons per year of Sodium Bisulfite Solution, 38% is an estimate. The Cambridge WWTP is located at 1010 Roslyn Avenue, Cambridge, MD 21613 Important Events:OngoingOpen DateOnline PortalPosting date for the OpportunityFeb 27th 2024, 9:00 AM ESTN/AUpcomingBid OpeningOnline - MS TeamsAttend the bid Opening using this link:

href="https://teams.microsoft.com/l/meetup-join/19%3ameeting_ZDRkZmEwZTMtMjJlZi00MGI4LThhYTMtMmNjZTgzMjY0NWZl%40thread.v2/0?context=%7b%22Tid%22%3a%224c44e1cf-7dae-454f-a18f-c18a6a12f9d7%22%2c%22Oid%22%3a%22258e8105-1d06-446c-8f6c-9ed710615f21%22%7d" target="_blank">https://teams.microsoft.com/l/meetup-join/19%3ameeting_ZDRkZmEwZTMtMjJlZi00MGI4LThhYTMtMmNjZTgzMjY0NWZl%40thread.v2/0?context=%7b%22Tid%22%3a%224c44e1cf-7dae-454f-a18f-c18a6a12f9d7%22%2c%22Oid%22%3a%22258e8105-1d06-446c-8f6c-9ed710615f21%22%7d Or call in (audio only) +1 332-249-0605,,989285415# United States, Baltimore Meeting ID: 989 285 415# Passcode: nCYTu4Mar 8th 2024, 12:00 PM EST - Mar 8th 2024, 12:30 PM ESTNoUpcomingClose DateOnline PortalDeadline for SubmissionsMar 8th 2024, 12:00 PM ESTN/AUpcomingIntent to Bid Due DateOnline PortalDeadline to indicate your intent to BidMar 8th 2024, 12:00 PM ESTYesPassedQuestions Due DateOnline PortalDeadline to submit QuestionsMar 1st 2024, 12:00 PM ESTN/A Supporting Documentation:1-24-2-32-5R SBR COMMODITIES.pdfDocumentationFeb 27th 2024, 9:03 AM EST - 1-24-2-32-5R Addendum No. 1.pdfAddendaFeb 29th 2024, 12:25 PM EST - Commodity Codes: UNSPSC 12 Chemicals including Bio Chemicals and Gas Materials: This segment includes inorganic and organic chemicals and compounds in solid, liquid or gaseous form used in an industrial or manufacturing process UNSPSC 12141806 Sodium Na UNSPSC 12352316 Sodium hydroxide: A chemical compound known as NaOH UNSPSC 50501805 Sodium monofluorophosphate: This classification denotes a nutritional supplement with the molecular formula FO3P.2Na, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier C810JCZ56Q, chemically known as phosphorofluoridic acid, sodium salt but more generally known as sodium monofluorophosphate, which bears U.S. NIH Compound Identifier 24266. European Medicines Agency schedules Sodium monofluorophosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB33441. World Health Organization schedules sodium monofluorophosphate in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. UNSPSC 51101677 Sodium stibogluconate: This classification denotes an enzyme inhibitor and antiparasitic agent with the molecular formula C12H18O17Sb2.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V083S0159D, chemically known as trinatrium bis(gluconato(3)-o2,o3,o4)hydroxooxido-oxy-bis-antimonat(v) but generally known as sodium stibogluconate, which bears US NIH Compound Identifier 16683012. European Medicines Agency schedules Sodium stibogluconate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04492MIG. World Health Organization schedules sodium stibogluconate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule Sodium stibogluconate under HS 29420000 and SITC 51699. As of Q4 2014, SODIUM STIBOGLUCONATE remains the US FDA Preferred Term for this commodity. Sodium stibogluconate bears US NLM identifiers UMLS ID C0030895 and NCI Concept Code C61083. SMILES: C([C@H]([C@@H]1[C@@H]([C@@H](O[SB](=O)(O1)O[SB]2(=O)O[C@@H]([C@@H]([C@@H](O2)C(=O)[O-])O)[C@@H](CO)O)C(=O)[O-])O)O)O.[NA+].[NA+]. UNSPSC 51111907 Sodium phenylbutyrate: This classification denotes a phenylbutyrate and antineoplastic agent with the molecular formula C10H11O2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NT6K61736T, chemically known as benzenebutanoic acid, sodium salt but generally known as sodium phenylbutyrate, which bears US NIH Compound Identifier 15585. European Medicines Agency schedules Sodium phenylbutyrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12586MIG. World Health Organization schedules sodium phenylbutyrate in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, SODIUM PHENYLBUTYRATE remains the US FDA Preferred Term for this commodity. Sodium phenylbutyrate bears US NLM identifiers UMLS ID C0718066 and NCI Concept Code C1440. SMILES: C1=CC=C(C=C1)CCCC(=O)[O-].[NA+]. UNSPSC 51112206 Sodium chloride/vinblastine: This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AN900. This VA Drug Class (AN900) classifies this compound as belonging to the group ANTINEOPLASTIC, OTHER. UNSPSC 51131521 Sodium feredetate: This classification denotes a nutritional supplement with the molecular formula C10H12N2O8.Fe.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 403J23EMFA, chemically known as sodium (n,n,n,n-ethylenediaminetetraacetato)ferrate(1-) but generally known as sodium feredetate, which bears US NIH Compound Identifier 27461. European Medicines Agency schedules Sodium feredetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10560MIG. World Health Organization schedules sodium feredetate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule sodium feredetate under HS 29224995 and SITC 51465. As of Q4 2014, SODIUM FEREDETATE remains the US FDA Preferred Term for this commodity. Sodium feredetate bears US NLM identifiers UMLS ID C0357084 and NCI Concept Code C76827. SMILES: C(CN(CC(=O)O)CC(=O)[O-])N(CC(=O)O)CC(=O)[O-].[Na+].[Fe+5]. UNSPSC 51131605 Sodium citrate: This classification denotes an electrolyte replacement agent and anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1Q73Q2JULR. European Medicines Agency schedules Sodium citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12582MIG. Sodium citrate generally arises in the molecular formula C6H5NA3O7. The term 'sodium citrate' is a U.S. Pharmacopeial Convention designation. As of Q4 2014, SODIUM CITRATE remains the US FDA Preferred Term for this commodity. Sodium citrate bears US NLM identifiers UMLS ID C0142825 and NCI Concept Code C62075. SMILES: C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]. UNSPSC 51131606 Sodium apolate: This classification denotes an anticoagulant agent and a alkyl sulfonate, phosphogluconate dehydrogenase antagonists and inhibitor, polyvinyl, polyethylene, and sulfonic acid with the molecular formula C2H3NaO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9461405D9F, chemically known as sodium;ethenesulfonate but generally known as sodium apolate, which bears US NIH Compound Identifier 3270262. European Medicines Agency schedules Sodium Apolate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05545MIG. The term SODIUM APOLATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Vol 20 1966, List 6). Most nations schedule sodium apolate under HS 39019090 and SITC 57190. SMILES: C=CS(=O)(=O)[O-].[Na+] UNSPSC 51142014 Sodium thiosalicylate: This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C7H5O2S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C2D9ITW04B, chemically known as 2-mercapto-benzoic acid, monosodium salt but generally known as sodium thiosalicylate, which bears US NIH Compound Identifier 8636. European Medicines Agency schedules Sodium thiosalicylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15331MIG. As of Q4 2014, SODIUM THIOSALICYLATE remains the US FDA Preferred Term for this commodity. Sodium thiosalicylate bears US NLM identifiers UMLS ID C0304347 and NCI Concept Code C87326. SMILES: SC1C(CCCC1)C(=O)O.[NA]. UNSPSC 51143109 Sodium salicylate: This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WIQ1H85SYP. European Medicines Agency schedules Sodium salicylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12306MIG. Sodium salicylate generally arises in the molecular formula C7H5NAO3. The term 'sodium salicylate' is a United States Homeopathic Pharmacopoeia Name designation. As of Q4 2014, SODIUM SALICYLATE remains the US FDA Preferred Term for this commodity. Sodium salicylate bears US NLM identifiers UMLS ID C0037549 and NCI Concept Code C834. SMILES: C1=CC=C(C(=C1)C(=O)[O-])O.[Na+]. UNSPSC 51171622 Sodium phosphate: This classification denotes an electrolyte replacement agent with the molecular formula NAH2PO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SE337SVY37, more generally known as sodium phosphate. European Medicines Agency schedules sodium phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12587MIG. The term SODIUM PHOSPHATE is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 25 , no. 10 1971, list 11. Most nations schedule sodium phosphate under HS 28444030 and SITC 52519. As of Q4 2014, SODIUM PHOSPHATE remains the US FDA Preferred Term for this commodity. Sodium phosphate bears US NLM identifiers UMLS ID C0074757 and NCI Concept Code C29459. SMILES: [O-]P(=O)([O-])[O-].[NA+].[NA+].[NA+]. UNSPSC 51171629 Sodium sulfate: This classification denotes an electrolyte replacement agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0YPR65R21J. European Medicines Agency schedules Sodium sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15325MIG. Sodium sulfate generally arises in the molecular formula NA2O4S. The term 'sodium sulfate' is a United States Homeopathic Pharmacopoeia Name designation. As of Q4 2014, SODIUM SULFATE remains the US FDA Preferred Term for this commodity. Sodium sulfate bears US NLM identifiers UMLS ID C0074769 and NCI Concept Code C47727. SMILES: S(=O)(=O)(O)O. UNSPSC 51171654 Sulisatin sodium: This classification denotes a laxative C21H15NO9S2.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7S636L78GU, chemically known as 2h-indol-2-one, 1,3-dihydro-7-methyl-3,3-bis(4-(sulfooxy)phenyl)-, sodium salt (1:2), but more generally known as sulisatin sodium, which bears US NIH Compound Identifier 41237. European Medicines Agency schedules Sulisatin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04641MIG. Most nations, for tariff and trade purposes, schedule sulisatin sodium under HS 29337900 and SITC 51561. As of Q4 2014, SULISATIN SODIUM remains US FDA's Preferred Term for this commodity. SMILES: CC1CCCC2C1NC(=O)C2(C3CCC(CC3)OS(=O)(=O)[O-])C4CCC(CC4)OS(=O)(=O)[O-].[NA+].[NA+]. UNSPSC 51172315 Sodium thiosulfate or thiosulfate or thiosulphate: This classification denotes a protective agent with the molecular formula 2Na.O3S2.5H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HX1032V43M, chemically known as thiosulfuric acid (h2s2o3), disodium salt but generally known as sodium thiosulfate, which bears US NIH Compound Identifier 24477. European Medicines Agency schedules Sodium thiosulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15332MIG. SMILES: [O-]S(=O)(=S)[O-].[NA+].[NA+]. UNSPSC 51172326 Sodium edetate: This classification denotes a chelating agent with the molecular formula C10H12N2O8.4Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MP1J8420LU, chemically known as tetrasodium ethylenediamine-n,n,n,n-tetraacetate but generally known as edetate sodium, which bears US NIH Compound Identifier 6144. European Medicines Agency schedules Edetate sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB37153. World Health Organization schedules edetate sodium in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule sodium edetate under HS 29224990 and SITC 51465. SMILES: [NA].[NA].[NA].[NA].OC(=O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O. UNSPSC 51172327 Sodium lactate: This classification denotes an electrolyte replacement agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TU7HW0W0QT. European Medicines Agency schedules Sodium lactate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15300MIG. Sodium lactate generally arises in the molecular formula C3H6O3.NA. The term SODIUM LACTATE is a United States Homeopathic Pharmacopoeia Name designation. Most nations schedule sodium lactate under HS 29181100 and SITC 51391. As of Q4 2014, SODIUM LACTATE remains the US FDA Preferred Term for this commodity. Sodium lactate bears US NLM identifiers UMLS ID C0142874 and NCI Concept Code C47726. SMILES: OC(C)C(=O)O. UNSPSC 51172480 Sodium bicarbonate/sodium citrate: This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA110. This VA Drug Class (GA110) classifies this compound as belonging to the group SODIUM BICARBONATE CONTAINING ANTACIDS. UNSPSC 51172506 Sodium chloride/sodium sulfite/sodium thiosulfate: This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AD200. This VA Drug Class (AD200) classifies this compound as belonging to the group CYANIDE ANTIDOTES. UNSPSC 51172837 Sodium biphosphate/sodium fluoride: This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OR100. This VA Drug Class (OR100) classifies this compound as belonging to the group CARIOSTATICS, TOPICAL. UNSPSC 51182440 Sodium cellulose phosphate: This classification denotes a cation exchange resins and column chromatography, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier E6S1NJ4Y5Q. European Medicines Agency schedules Sodium cellulose phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15280MIG. Sodium cellulose phosphate generally arises in the molecular formula (C6H7O5)N.NA.O3P.H. The term 'sodium cellulose phosphate' is a United States Adopted Name designation. UNSPSC 51191602 Sodium chloride electrolytes: This classification denotes an electrolyte solution, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 451W47IQ8X, chemically known as sodium;chloride, more generally known as sodium chloride or saline, US NIH Compound Identifier 5234. European Medicines Agency schedules Sodium chloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12581MIG. Sodium chloride generally arises in the molecular formula CLNA. The term 'sodium chloride' is an FDA designation, but the term COMPOUND SOLUTION OF SODIUM CHLORIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, 1955, 9, 185-194, List 1.) SMILES: [Na+].[Cl-].